Modulation of transforming growth factor beta2 (TGF-beta2) by inositol hexaphosphate in colon carcinogenesis in rats

Acta Cirurgica Brasileira

Volumn 21, Issue SUPPL. 4, 2006, Pages 51-56

  Marks, Guido ^a,c   Aydos, Ricardo Dutra ^a   Fagundes, Djalma José ^b   Pontes, Elenir Rose Jardim Cury ^a   Takita, Luiz Carlos ^a   Do Amaral, Eva Glória Abrão Siufi ^a   Rossini, Airton ^a   Ynouye, Celso Massaschi ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Azoxymethane; Phytic acid; Rats; Transforming growth factor beta

Indexed keywords

AZOXYMETHANE; DRINKING WATER; PHYTIC ACID; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOGENESIS; COMPUTER ANALYSIS; CONTROLLED STUDY; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; AZOXYMETHANE; CARCINOGENICITY TESTS; CARCINOGENS; COLON; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; PHYTIC ACID; RATS; TRANSFORMING GROWTH FACTOR BETA2;

EID: 33846895878     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502006001000012     Document Type: Article

References (22)

1. De Caestecker MP, Piek E, Roberts AB. Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst. 2000;92:1388-402.
2. Massague J. How cells read TGF beta signals. Nat Rev Mol Cell Biol. 2000;1:169-78.
3. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts, Paracrine cells important in health and disease. Am J Physiol. 1999; 277:1-9.
4. Koli K, Saharinen J, Hyytiainen M, Penttinen C, Keski-Oja, J. Latency, activation, and binding proteins of TGF beta. Microsc Res Tech. 2001;52:354-62.
5. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci. 2003; 116:217-24.
6. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF beta in homeostasis and cancer. Nat Rev Cancer. 2003;3:807-20.
7. Fox CH, Eberl M. Phytic acid (IP6), a novel broad espectrum anti-neoplastic agent: systematic review. Complementary Therapies in Medicine. 2002;10:229-34.
8. Barcellos-Hoff MH, Dix TA. Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol. 1996;10:1077-83.
9. Rady W, Myerroff L, Swinler S, Rajput A, Thiagalingam S. Mutacional inactivation of transforming growth factor β receptor type II in microsatelite stable colon cancers. Cancer Res. 1999; 59:320-4.
10. Chung, DC. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology. 2000;119:854-65.
11. Go VL, Butrum RR, Wong DA. Diet, nutrition, and cancer prevention: the postgenomic era. J Nutr. 2003;133:3830-6.
12. Jenab M, Thompson LU. The influence of phytic acid in wheat bran on early biomarkers of colon carcinogenesis. Carcinogenesis. 1998;19:1087-92.
13. Pretlow TP, O'Riordan MA, Somich GA, Amini SB, Pretlow TG. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis. 1992;13:1509-12.
14. Lasko CM, Bird RP Modulation of aberrants crypt foci by dietary fat and caloric restriction: the effects of delayed intervention. Cancer Epidemiol Biomarkers Prev. 1995;4:49-55.
15. Seidal T, Balaton AJ, Battifora H. Interpretation and quantification of immunostains. Am J Surg Pathol. 2001;25:1204-7.
16. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 2001;23(4):291-9.
17. Oliveira AC, Reis SMPM, Carvalho EM, Pimenta A , Fernan FMV, Rios KR, Paiva KC, Sousa LM, Almeida M, Arruda SF. Adiçöes crescentes de ácido fítico à dieta näo interferiram na digestibilidade da caseína e no ganho de peso em ratos. Rev Nutr. 2003;16:211-7.
18. Raju J, Bird RP. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. Cancer Res. 2003;63:6595-601.
19. Kishimoto Y, Morisawa T, Hosoda A, Shiota G, Kawasaki H, Hasegawa J. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. J Exp Clin Cancer Res. 2003;21:203-11.
20. Jenab M, Thompson LU. Phytic acid in wheat bran affects colon morphology, cell differentiation and apoptosis. Carcinogenesis. 2000;21:1547-52.
21. Uchida K, Kado S, Ando M, Nagata Y, Takagi A, Onoue M. A mucinous histochemical study on malignancy of aberrant crypt foci (ACF) in rat colon. J Vet Med Sci. 2001;63:145-9.
22. Bolognesi C, Mariani MR, Boffa LC. Target tissue DNA damage in inbred mouse strains with different susceptibility to the colon carcinogen 1,2-dimethylhydrazine. Carcinogenesis. 1988; 9:1347-50.